Table 6

Multivariate Analysis Including CMR Parameters (N = 539)

Clinical + LVEF*Clinical + LGE†Clinical + GCS‡Clinical + LVEF + LGE§Clinical + LVEF + LGE + GCS‖
HR (95% CI)p ValueHR (95% CI)p ValueHR (95% CI)p ValueHR (95% CI)p ValueHR (95% CI)p Value
IHD3.70 (2.04–6.69)<0.0012.84 (1.53–5.31)0.0013.95 (2.17–7.17)<0.0012.70 (1.41–5.14)0.0032.71 (1.41–5.21)0.003
Beta-blocker use1.58 (0.74–3.34)0.232.93 (1.47–5.84)0.0021.96 (0.95–4.05)0.071.62 (0.77–3.42)0.201.45 (0.68–3.08)0.34
LVEF (%)0.94 (0.92–0.96)<0.0010.95 (0.93–0.97)<0.0010.96 (0.94–0.99)0.005
LGE present3.46 (1.82–6.59)<0.0012.14 (1.06–4.33)0.0272.07 (1.03–4.14)0.040
GCS (%)1.22 (1.14–1.31)<0.0011.11 (1.02–1.21)0.041

Chi-square: *126.46; †94.12; ‡105.26; §130.07 (p < 0.05 vs. Clinical + LVEF model); and ‖133.60 (p < 0.05 vs. Clinical + LVEF model).

IHD = ischemic heart disease; GCS = global circumferential strain; LGE = late gadolinium enhancement; LVEF = left ventricular ejection fraction; other abbreviations as in Tables 2 and 5.